跳至主要内容
临床试验/ACTRN12621000190808
ACTRN12621000190808已完成未知

The effect of pine bark extract dietary supplement on fasting plasma malondialdehyde (MDA) concentrations in healthy older adults

niversity of Newcastle0 个研究点目标入组 62 人开始时间: 2021年2月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
55 Years 至 75 Years(—)
性别
All

入选标准

  • Healthy adults aged 55 to 75 years old without existing chronic diseases
  • Gender: both males and females

排除标准

  • Diagnosed chronic diseases and/or are being treated for chronic diseases e.g. cardiovascular disease, cancer, type 2 diabetes, chronic kidney disease, liver failure, pancreatitis, inflammatory bowel disease etc
  • Currently taking any medication and/or supplements known to have anti-inflammatory, antioxidant, blood pressure-lowering, immunosuppressant or anticoagulant effects
  • Recently commenced a dietary intervention in the past 3 months or made significant changes to their dietary patterns, food choices, lifestyle and/or physical activity levels in the past 3 months
  • Allergic or intolerant to figs, kiwifruit and papaya
  • Pregnant or breast-feeding

研究者

发起方
niversity of Newcastle

相似试验